Elizabeth A. Mullen, MD, FAAP

Elizabeth Mullen, MD, FAAP

Physician

Assistant Professor of Pediatrics, Harvard Medical School

    Contact: 617-632-1938
  • Fax: 617-632-5710

Medical Services

Specialties

  • Hematology Oncology
  • Wilms Tumor

Departments

  • Hematology / Oncology
  • Medicine

Programs

  • Kidney Tumor Program
To schedule an appointment: Call 617-632-1938

Experience and Education

Education

Medical School

Yale University School of Medicine, 1992

New Haven, CT

Pediatric Hematology/Oncology

Children's Hospital Boston/Dana-Farber Cancer Institute, 1995-1997

Boston, MA

Pediatrics

Boston Children's Hospital , 1992-1993

Boston, MA

Pediatrics

Boston Combined Residency Program, Children's Hospital Boston/Boston Medical Center, 1993-1995

Boston, MA

Certifications

  • Pediatrics, Pediatric Hematology/Oncology

Research

Pediatric Renal Tumors

Publications

Publications powered by Harvard Catalyst Profiles
  1. Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ. Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations. Hum Pathol. 2016 Feb; 48:81-7.
  2. Geller JI, Ehrlich PF, Cost NG, Khanna G, Mullen EA, Gratias EJ, Naranjo A, Dome JS, Perlman EJ. Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2. Cancer. 2015 Jul 15; 121(14):2457-64.
  3. Doros LA, Rossi CT, Yang J, Field A, Williams GM, Messinger Y, Cajaiba MM, Perlman EJ, A Schultz K, Cathro HP, Legallo RD, LaFortune KA, Chikwava KR, Faria P, Geller JI, Dome JS, Mullen EA, Gratias EJ, Dehner LP, Hill DA. DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol. 2014 Sep; 27(9):1267-80.
  4. Hamilton TE, Barnhart D, Gow K, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Gratias E, Geller J, Mullen E, Ehrlich P. Inter-rater reliability of surgical reviews for AREN03B2: a COG renal tumor committee study. J Pediatr Surg. 2014 Jan; 49(1):154-8; discussion 158.
  5. Armon BD, Mullen EA. Uncle Sam and your job options. Considering your next career move? Consider the tax implications. Del Med J. 2013 May; 85(5):147-9.
  6. Gow KW, Barnhart DC, Hamilton TE, Kandel JJ, Chen MK, Ferrer FA, Price MR, Mullen EA, Geller JI, Gratias EJ, Rosen N, Khanna G, Naranjo A, Ritchey ML, Grundy PE, Dome JS, Ehrlich PF. Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee. J Pediatr Surg. 2013 Jan; 48(1):34-8.
  7. Dome JS, Fernandez CV, Mullen EA, Kalapurakal JA, Geller JI, Huff V, Gratias EJ, Dix DB, Ehrlich PF, Khanna G, Malogolowkin MH, Anderson JR, Naranjo A, Perlman EJ. Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer. 2013 Jun; 60(6):994-1000.
  8. Fernandez CV, Li N, Mullen EA, Grundy PE, Perman EJ, Shamberger RC, Ehrlich PF, Dome JS. Barriers to the enrollment of children in the Children's Oncology Group study of very low risk Wilms tumor: a report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2011 Oct; 33(7):521-3.
  9. Metzger ML, Stewart CF, Freeman BB, Billups CA, Hoffer FA, Wu J, Coppes MJ, Grant R, Chintagumpala M, Mullen EA, Alvarado C, Daw NC, Dome JS. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study. J Clin Oncol. 2007 Jul 20; 25(21):3130-6.
  10. E A Mullen. Pediatric Oncologic Emergencies. Nathan & Oski's Hematology Textbook of Infancy and Childhood. 2007; In Press.
  11. Show all
  12. Kolden GG, Chisholm-Stockard SM, Strauman TJ, Tierney SC, Mullen EA, Schneider KL. Universal session-level change processes in an early session of psychotherapy: path models. J Consult Clin Psychol. 2006 Apr; 74(2):327-36.
  13. EA Mullen. Section Editor, Oncology. Pediatric Hospitalist Textbook, Chiang. 2006.
  14. EA Mullen. Oncologic Emergencies Chapter. Pediatric Hospitalist Textbook, Chiang. 2006.
  15. Vaurio LE, Sands LP, Wang Y, Mullen EA, Leung JM. Postoperative delirium: the importance of pain and pain management. Anesth Analg. 2006 Apr; 102(4):1267-73.
  16. Mullen E, Skitka LJ. Exploring the psychological underpinnings of the moral mandate effect: motivated reasoning, group differentiation, or anger? J Pers Soc Psychol. 2006 Apr; 90(4):629-43.
  17. Mullen EA. Section Editor, Oncology. Pediatric Hospitalist Textbook. 2006.
  18. B Mueller, M Dinu, R Bryant, E Mullen J Yan, C Brugnara. The Safety of Oral Magnesium Pidolate in Children with Hemoglobin SC Disease. Presented at the 28th Annual Meeting of the National Sickle Cell Disease Program. 2005.
  19. Jones M, Campbell KA, Duggan C, Young G, Bousvaros A, Higgins L, Mullen E. Multiple micronutrient deficiencies in a child fed an elemental formula. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):602-5.
  20. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clincial Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Acute Chest. 2001.
  21. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines on the treatment of patients with Sickle Cell Disease, on the topic of Transfusion. 2001.
  22. Jones, Monica; Campbell, Katie A.; Duggan, Christopher; Young, Gregory; Bousvaros, Athos; Higgins, Laurie; Mullen, Elizabeth . Multiple Micronutrient Deficiencies in a Child Fed an Elemental Formula. Journal of Pediatric Oncology. 2001; (5):602-605.
  23. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Pain. 2000.
  24. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Routine Health Maintainence and Priapism. 2000.
  25. E. Mullen, Lead Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Fever. 2000.
  26. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Splenic Sequestration. 2000.
  27. E. Mullen, Co-Author, and the Children's Hospital Clinical Practice Guideline Committee. . Clinical Practice Guidelines for the treatment of Pain in Sickle Cell Disease. 2000.
  28. E. Mullen, Lead Author, and the Children's Hospital Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of Fever in Sickle Cell Disease. 2000.
  29. E. Mullen, Co-Author, and the Children's Hospital Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of Fever and Neutropenia. 2000.
  30. Szabo S, Pihan G, Raza A, Mullen EA, Hauschka PV. Multiple Mechanisms of Cell Injury in the Gastric Mucosa. Federal Proceedings. 1991; 46:1152.
  31. Mullen EA. Biochemical Characterization of a Boving Corneal Angiogenesis Inhibitor. 1991.
  32. Mullen EA, McKee MD, Hauschka PV. . Fluorogenic Assay of Proteinase Activity in Developing Rat Enamel. Journal of Dental Research. 1989; 68:239.
  33. Hauschka PV, Mullen EA, Hintsch G, Jazwinski S. Abundant Occurrence of Gamma-Carboxyglutamic Acid-Containing Peptides in the Gastropod Family. Current Advances in Vitamin K Research. Ed. John Suttie. 1988.
  34. Mullen, EA. An examination of the Vitamin K Cycle: Phenytoin Interference in K-dependent Carboxylase Activity. 1985.
  35. Khanna G, Naranjo A, Hoffer F, Mullen E, Geller J, Gratias EJ, Ehrlich PF, Perlman EJ, Rosen N, Grundy P, Dome JS. Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group. Radiology. 2013 Feb; 266(2):610-7.
  36. Ferrer FA, Herbst KW, Fernandez CV, Khanna G, Dome JS, Naranjo A, Mullen EA, Geller JI, Gratias EJ, Shamberger R, Ritchey M, Ehrlich PF. Feasibility of using CT volume as a predictor of specimen weight in a subgroup of patients with low risk Wilms tumors registered on COG Study AREN03B2: implications for central venous catheter placement. J Pediatr Urol. 2014 Oct; 10(5):969-73.
  37. Servaes S, Khanna G, Naranjo A, Geller JI, Ehrlich PF, Gow KW, Perlman EJ, Dome JS, Gratias E, Mullen EA. Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group. Pediatr Radiol. 2015 Feb; 45(2):166-72.
  38. Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, Van den Heuvel-Eibrink M, Pritchard-Jones K. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. J Clin Oncol. 2015 Sep 20; 33(27):2999-3007.
  39. Ehrlich PF, Hamilton TE, Gow K, Barnhart D, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Perlman EJ, Kalapurakal JA, Khanna G, Dome JS, Geller J, Mullen E. Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2016 Nov; 63(11):1905-10.
  40. Gratias EJ, Dome JS, Jennings LJ, Chi YY, Tian J, Anderson J, Grundy P, Mullen EA, Geller JI, Fernandez CV, Perlman EJ. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. J Clin Oncol. 2016 Sep 10; 34(26):3189-94.
  41. Yi JS, Kamihara J, Kesselheim JC, Davies K, van Hoff J, Silverman LB, Mullen EA. Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan. Pediatr Blood Cancer. 2016 Nov 15.
To schedule an appointment: Call 617-632-1938

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close